» Articles » PMID: 15614130

Neutrophil Elastase, MIP-2, and TLR-4 Expression During Human and Experimental Sepsis

Overview
Journal Shock
Date 2004 Dec 23
PMID 15614130
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Highly activated neutrophils play a critical role in mediating organ injury in sepsis by releasing neutrophil elastase (NE). Toll-like receptors (TLRs) play an important role in the host defense against invading microbes, and their signaling pathway is critical to the activation of the proinflammatory response. However, the relationship between TLR expression and the host defense mechanism during sepsis has not been fully elucidated. In this paper, we investigated the relationships among chemokine (MIP-2), TLR-4, and NE expression in human sepsis and murine peritonitis (CLP). TLR-4 expression on monocytes/macrophages was examined in patients with sepsis and in murine peritonitis and was markedly increased in both populations. LPS-induced MIP-2 production by bronchoalveolar cells and liver mononuclear cells in mice with peritonitis was also significantly increased compared with sham-operated mice. Pretreatment of the macrophage cell line, RAW 264.7 cells, with a NE inhibitor before their exposure to LPS resulted in a significant dose-dependent decrease in MIP-2 production, which was comparable to that seen following pretreatment with TLR-4 antibody. Furthermore, NE and LPS both up-regulated TLR-4 expression on human peripheral blood monocytes. Thus, chemokine-induced recruitment of neutrophils in sepsis may result in further increased chemokine production and increased expression of TLR-4. Neutrophil-derived NE may be associated with increased expression of monocyte/macrophage TLR-4, thereby serving as a positive feedback loop for the inflammatory response among the different cell populations.

Citing Articles

Bacteria-derived extracellular vesicles: endogenous roles, therapeutic potentials and their biomimetics for the treatment and prevention of sepsis.

Effah C, Ding X, Drokow E, Li X, Tong R, Sun T Front Immunol. 2024; 15:1296061.

PMID: 38420121 PMC: 10899385. DOI: 10.3389/fimmu.2024.1296061.


Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning.

Wiffen L, DCruz L, Brown T, Higenbottam T, Bernstein J, Campbell C Front Immunol. 2023; 14:1192765.

PMID: 37731491 PMC: 10508987. DOI: 10.3389/fimmu.2023.1192765.


Host-Derived Cytotoxic Agents in Chronic Inflammation and Disease Progression.

Arnhold J Int J Mol Sci. 2023; 24(3).

PMID: 36769331 PMC: 9918110. DOI: 10.3390/ijms24033016.


Role of Microbial Infection-Induced Inflammation in the Development of Gastrointestinal Cancers.

Kouzu K, Tsujimoto H, Kishi Y, Ueno H, Shinomiya N Medicines (Basel). 2021; 8(8).

PMID: 34436224 PMC: 8400127. DOI: 10.3390/medicines8080045.


Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.

Root-Bernstein R Int J Mol Sci. 2021; 22(4).

PMID: 33672738 PMC: 7924650. DOI: 10.3390/ijms22042108.